Katia Balmas Bourloud

879 total citations
19 papers, 719 citations indexed

About

Katia Balmas Bourloud is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Katia Balmas Bourloud has authored 19 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 12 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Katia Balmas Bourloud's work include Neuroblastoma Research and Treatments (18 papers), Cell death mechanisms and regulation (7 papers) and Lung Cancer Research Studies (6 papers). Katia Balmas Bourloud is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), Cell death mechanisms and regulation (7 papers) and Lung Cancer Research Studies (6 papers). Katia Balmas Bourloud collaborates with scholars based in Switzerland, France and United States. Katia Balmas Bourloud's co-authors include Annick Mühlethaler‐Mottet, Nicole Groß, Jean-Luc Bodmer, Sally Hopkins-Donaldson, Jean‐Marc Joseph, Jürg Tschopp, Marjorie Flahaut, Roland Meier, Pu Yan and Katya Nardou and has published in prestigious journals such as PLoS ONE, Oncogene and Experimental Cell Research.

In The Last Decade

Katia Balmas Bourloud

18 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katia Balmas Bourloud Switzerland 15 532 284 221 175 137 19 719
Hauke Sieverts Germany 8 506 1.0× 205 0.7× 214 1.0× 121 0.7× 133 1.0× 13 749
Samuele Gherardi Italy 13 538 1.0× 287 1.0× 176 0.8× 184 1.1× 35 0.3× 20 730
Kristina Althoff Germany 14 547 1.0× 256 0.9× 154 0.7× 197 1.1× 85 0.6× 21 727
Marli E. Ebus Netherlands 12 452 0.8× 317 1.1× 243 1.1× 162 0.9× 35 0.3× 14 681
Andrew E. Tee Australia 16 746 1.4× 179 0.6× 133 0.6× 373 2.1× 40 0.3× 18 909
Daniela Opel Germany 5 388 0.7× 196 0.7× 78 0.4× 139 0.8× 40 0.3× 6 471
Donia M. Moujalled Australia 9 538 1.0× 91 0.3× 73 0.3× 81 0.5× 210 1.5× 17 689
Wendy Fang United States 9 383 0.7× 86 0.3× 100 0.5× 165 0.9× 55 0.4× 17 563

Countries citing papers authored by Katia Balmas Bourloud

Since Specialization
Citations

This map shows the geographic impact of Katia Balmas Bourloud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katia Balmas Bourloud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katia Balmas Bourloud more than expected).

Fields of papers citing papers by Katia Balmas Bourloud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katia Balmas Bourloud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katia Balmas Bourloud. The network helps show where Katia Balmas Bourloud may publish in the future.

Co-authorship network of co-authors of Katia Balmas Bourloud

This figure shows the co-authorship network connecting the top 25 collaborators of Katia Balmas Bourloud. A scholar is included among the top collaborators of Katia Balmas Bourloud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katia Balmas Bourloud. Katia Balmas Bourloud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Colombo, Daniele, Rajendran Sanalkumar, Liliane C. Broye, et al.. (2024). Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma. JCI Insight. 9(14).
2.
Mühlethaler‐Mottet, Annick, Silvia Uccella, Stefano La Rosa, et al.. (2022). Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension. Frontiers in Endocrinology. 13. 1027856–1027856. 2 indexed citations
3.
Praz, Viviane, Katia Balmas Bourloud, Jean‐Marc Joseph, et al.. (2022). TWIST1 expression is associated with high-risk neuroblastoma and promotes primary and metastatic tumor growth. Communications Biology. 5(1). 42–42. 7 indexed citations
4.
Abid, Karim, Maja Beck‐Popovic, Katia Balmas Bourloud, et al.. (2021). The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation. Oncotarget. 12(1). 49–60. 2 indexed citations
5.
Flahaut, Marjorie, Katya Nardou, Katia Balmas Bourloud, et al.. (2016). Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma. BMC Cancer. 16(1). 781–781. 39 indexed citations
6.
Mühlethaler‐Mottet, Annick, Kelly Ascenção, Marjorie Flahaut, et al.. (2015). The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing. PLoS ONE. 10(5). e0125616–e0125616. 23 indexed citations
7.
Coulon, Aurélie, Michel Peuchmaur, Marjorie Flahaut, et al.. (2014). Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells. Oncotarget. 5(12). 4452–4466. 29 indexed citations
8.
Mühlethaler‐Mottet, Annick, Marjorie Flahaut, Katia Balmas Bourloud, et al.. (2011). Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis. Cell Death and Disease. 2(3). e125–e125. 23 indexed citations
9.
Mühlethaler‐Mottet, Annick, Roland Meier, Marjorie Flahaut, et al.. (2008). Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells. Molecular Cancer. 7(1). 55–55. 55 indexed citations
10.
Meier, Roland, Annick Mühlethaler‐Mottet, Marjorie Flahaut, et al.. (2007). The Chemokine Receptor CXCR4 Strongly Promotes Neuroblastoma Primary Tumour and Metastatic Growth, but not Invasion. PLoS ONE. 2(10). e1016–e1016. 49 indexed citations
11.
Flahaut, Marjorie, Annick Mühlethaler‐Mottet, Danielle Martinet, et al.. (2006). Molecular cytogenetic characterization of doxorubicin‐resistant neuroblastoma cell lines: Evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region. Genes Chromosomes and Cancer. 45(5). 495–508. 19 indexed citations
12.
Mühlethaler‐Mottet, Annick, Marjorie Flahaut, Katia Balmas Bourloud, et al.. (2006). Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio. BMC Cancer. 6(1). 214–214. 39 indexed citations
13.
14.
15.
Hopkins-Donaldson, Sally, Pu Yan, Katia Balmas Bourloud, et al.. (2002). Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells. Oncogene. 21(39). 6132–6137. 41 indexed citations
16.
Yan, Pu, et al.. (2002). Hypermethylation‐mediated regulation of CD44 gene expression in human neuroblastoma. Genes Chromosomes and Cancer. 36(2). 129–138. 36 indexed citations
17.
Bourloud, Katia Balmas, et al.. (2000). MYCN-Related Suppression of Functional CD44 Expression Enhances Tumorigenic Properties of Human Neuroblastoma Cells. Experimental Cell Research. 260(2). 396–403. 24 indexed citations
18.
Hopkins-Donaldson, Sally, et al.. (2000). Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis. Medical and Pediatric Oncology. 35(6). 608–611. 41 indexed citations
19.
Hopkins-Donaldson, Sally, et al.. (2000). Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.. PubMed. 60(16). 4315–9. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hauke Sieverts Breakdown of academic impact, for papers by Samuele Gherardi Breakdown of academic impact, for papers by Kristina Althoff Breakdown of academic impact, for papers by Marli E. Ebus Breakdown of academic impact, for papers by Andrew E. Tee Breakdown of academic impact, for papers by Daniela Opel Breakdown of academic impact, for papers by Donia M. Moujalled Breakdown of academic impact, for papers by Wendy Fang
Rankless by CCL
2026